Table 5.
Baseline SSD T1ρ pLT (0.9, 5.6)b |
Baseline SSD T2 TrF (0.5, 2.2)b |
Total WORMS Cartilage Lesion (0.0, 3.8)b |
||||
---|---|---|---|---|---|---|
Outcomes | Mean | 95% CI | Mean | 95% CI | Mean | 95% CI |
Baseline (n = 51) | ||||||
KOOS | ||||||
Pain | −8.92 | −15.4 to −2.5 | −0.57 | −4.5 to 3.4 | −6.58 | −14.8 to 1.6 |
Symptoms | −6.58 | −13.5 to 0.4 | 1.08 | −3.2 to 5.3 | −9.57 | −19.1 to 0.0 |
ADL | −9.12 | −15.2 to −3.0 | −0.88 | −4.6 to 2.8 | −8.25 | −16.6 to 0.1 |
Sports | −13.36 | −24.7 to −2.0 | 0.66 | −6.2 to 7.6 | 2.76 | −12.6 to 18.1 |
QOL | −10.54 | −19.9 to −1.2 | 3.31 | −2.4 to 9.0 | −7.32 | −20.1 to 5.4 |
6-month Follow-up (n = 46) | ||||||
KOOS | ||||||
Pain | −5.50 | −10.6 to −0.4 | 0.39 | −2.7 to 3.5 | −8.45 | −15.7 to −1.2 |
Symptoms | −5.42 | −11.7 to 0.9 | 0.73 | −3.3 to 4.8 | −5.37 | −14.9 to 4.2 |
ADL | −0.49 | −4.3 to 3.4 | −1.05 | −3.2 to 1.2 | −7.65 | −12.8 to −2.4 |
Sports | −3.67 | −12.9 to 5.6 | 2.56 | −3.1 to 8.2 | −12.02 | −24.5 to 0.4 |
QOL | −2.52 | −9.9 to 4.9 | 4.29 | −0.8 to 9.4 | −10.58 | −21.2 to 0.1 |
1-year Follow-up (n = 42) | ||||||
KOOS | ||||||
Pain | −6.51 | −10.8 to −2.3 | −0.62 | −3.2 to 2.0 | −6.64 | −12.4 to −0.9 |
Symptoms | −6.15 | −11.5 to −0.8 | −0.94 | −4.4 to 2.5 | −5.22 | −12.9 to 2.5 |
ADL | −2.62 | −5.0 to −0.2 | −1.76 | −3.3 to −0.2 | −2.00 | −5.3 to 1.3 |
Sports | −6.50 | −13.8 to 0.8 | −0.99 | −5.7 to 3.7 | −2.37 | −12.2 to 7.5 |
QOL | −12.6 | −21.0 to −4.2 | 0.92 | −4.8 to 6.6 | −2.88 | −14.8 to 9.1 |
Marx | −2.33 | −4.0 to −0.7 | 0.21 | −1.1 to 1.5 | 1.89 | −0.5 to 4.2 |
SSD, side-to-side difference pLT, posterolateral tibia; TrF, femoral trochlea; WORMS, Whole-Organ MRI Scoring; CI, confidence interval; KOOS, Knee-Injury and Osteoarthritis Outcome Score; ADL, activities of daily living; QOL, knee-related quality-of-life. Bold denotes clinically meaningful changes.
Interquartile Range.